124 related articles for article (PubMed ID: 16451063)
21. Selective inhibitors of hepatitis C virus replication.
Neyts J
Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
[TBL] [Abstract][Full Text] [Related]
22. Discovery and preclinical evaluation of potent, orally bioavailable, metabolically stable cyclopropylindolobenzazepine acylsulfonamides as thumb site 1 inhibitors of the hepatitis c virus NS5B RNA-dependent, RNA polymerase.
Hewawasam P; Tu Y; Gao M; Hanumegowda U; Knipe J; Lemm JA; Parker DD; Rigat KL; Roberts SB; Meanwell NA; Kadow JF
Bioorg Med Chem Lett; 2016 Feb; 26(3):936-940. PubMed ID: 26747393
[TBL] [Abstract][Full Text] [Related]
23. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
[TBL] [Abstract][Full Text] [Related]
24. Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitors.
Bennett F; Kezar HS; Girijavallabhan V; Huang Y; Huelgas R; Rossman R; Shih NY; Piwinski JJ; MacCoss M; Kwong CD; Clark JL; Fowler AT; Geng F; Roychowdhury A; Reynolds RC; Maddry JA; Ananthan S; Secrist JA; Li C; Chase R; Curry S; Huang HC; Tong X; George Njoroge F; Arasappan A
Bioorg Med Chem Lett; 2012 Aug; 22(15):5144-9. PubMed ID: 22814211
[TBL] [Abstract][Full Text] [Related]
25. Discovery of novel P3 sulfonamide-capped inhibitors of HCV NS3 protease. Inhibitors with improved cellular potencies.
Venkatraman S; Blackman M; Wu W; Nair L; Arasappan A; Padilla A; Bogen S; Bennett F; Chen K; Pichardo J; Tong X; Prongay A; Cheng KC; Girijavallabhan V; George Njoroge F
Bioorg Med Chem; 2009 Jul; 17(13):4486-95. PubMed ID: 19481946
[TBL] [Abstract][Full Text] [Related]
26. Imidazo[4,5-c]pyridines inhibit the in vitro replication of the classical swine fever virus and target the viral polymerase.
Vrancken R; Paeshuyse J; Haegeman A; Puerstinger G; Froeyen M; Herdewijn P; Kerkhofs P; Neyts J; Koenen F
Antiviral Res; 2008 Feb; 77(2):114-9. PubMed ID: 17997169
[TBL] [Abstract][Full Text] [Related]
27. Quinoline tricyclic derivatives. Design, synthesis and evaluation of the antiviral activity of three new classes of RNA-dependent RNA polymerase inhibitors.
Carta A; Briguglio I; Piras S; Corona P; Boatto G; Nieddu M; Giunchedi P; Marongiu ME; Giliberti G; Iuliano F; Blois S; Ibba C; Busonera B; La Colla P
Bioorg Med Chem; 2011 Dec; 19(23):7070-84. PubMed ID: 22047799
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors.
Bosse TD; Larson DP; Wagner R; Hutchinson DK; Rockway TW; Kati WM; Liu Y; Masse S; Middleton T; Mo H; Montgomery D; Jiang W; Koev G; Kempf DJ; Molla A
Bioorg Med Chem Lett; 2008 Jan; 18(2):568-70. PubMed ID: 18068361
[TBL] [Abstract][Full Text] [Related]
29. Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor.
Li H; Tatlock J; Linton A; Gonzalez J; Jewell T; Patel L; Ludlum S; Drowns M; Rahavendran SV; Skor H; Hunter R; Shi ST; Herlihy KJ; Parge H; Hickey M; Yu X; Chau F; Nonomiya J; Lewis C
J Med Chem; 2009 Mar; 52(5):1255-8. PubMed ID: 19209845
[TBL] [Abstract][Full Text] [Related]
30. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
Hao W; Duggal R
Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
[TBL] [Abstract][Full Text] [Related]
31. Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents.
Dragovich PS; Blazel JK; Ellis DA; Han Q; Kamran R; Kissinger CR; LeBrun LA; Li LS; Murphy DE; Noble M; Patel RA; Ruebsam F; Sergeeva MV; Shah AM; Showalter RE; Tran CV; Tsan M; Webber SE; Kirkovsky L; Zhou Y
Bioorg Med Chem Lett; 2008 Oct; 18(20):5635-9. PubMed ID: 18796353
[TBL] [Abstract][Full Text] [Related]
32. Discovery of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator.
Ward SE; Harries M; Aldegheri L; Andreotti D; Ballantine S; Bax BD; Harris AJ; Harker AJ; Lund J; Melarange R; Mingardi A; Mookherjee C; Mosley J; Neve M; Oliosi B; Profeta R; Smith KJ; Smith PW; Spada S; Thewlis KM; Yusaf SP
J Med Chem; 2010 Aug; 53(15):5801-12. PubMed ID: 20614889
[TBL] [Abstract][Full Text] [Related]
33. 6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B.
Chen G; Ren H; Zhang N; Lennox W; Turpoff A; Paget S; Li C; Almstead N; Njoroge FG; Gu Z; Graci J; Jung SP; Colacino J; Lahser F; Zhao X; Weetall M; Nomeir A; Karp GM
Bioorg Med Chem Lett; 2015 Feb; 25(4):781-6. PubMed ID: 25613678
[TBL] [Abstract][Full Text] [Related]
34. Novel potent inhibitors of hepatitis C virus (HCV) NS3 protease with cyclic sulfonyl P3 cappings.
Chen KX; Vibulbhan B; Yang W; Nair LG; Tong X; Cheng KC; Njoroge FG
Bioorg Med Chem Lett; 2009 Feb; 19(4):1105-9. PubMed ID: 19168351
[TBL] [Abstract][Full Text] [Related]
35. Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor.
Quan ML; Lam PY; Han Q; Pinto DJ; He MY; Li R; Ellis CD; Clark CG; Teleha CA; Sun JH; Alexander RS; Bai S; Luettgen JM; Knabb RM; Wong PC; Wexler RR
J Med Chem; 2005 Mar; 48(6):1729-44. PubMed ID: 15771420
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.
Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M
Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922
[TBL] [Abstract][Full Text] [Related]
37. Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase.
Shaw AN; Tedesco R; Bambal R; Chai D; Concha NO; Darcy MG; Dhanak D; Duffy KJ; Fitch DM; Gates A; Johnston VK; Keenan RM; Lin-Goerke J; Liu N; Sarisky RT; Wiggall KJ; Zimmerman MN
Bioorg Med Chem Lett; 2009 Aug; 19(15):4350-3. PubMed ID: 19515564
[TBL] [Abstract][Full Text] [Related]
38. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
[TBL] [Abstract][Full Text] [Related]
39. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121
[TBL] [Abstract][Full Text] [Related]
40. A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase.
Paeshuyse J; Letellier C; Froeyen M; Dutartre H; Vrancken R; Canard B; De Clercq E; Gueiffier A; Teulade JC; Herdewijn P; Puerstinger G; Koenen F; Kerkhofs P; Baraldi PG; Neyts J
Antiviral Res; 2009 Jun; 82(3):141-7. PubMed ID: 19428605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
